Stifel resumes Celsius stock coverage with buy rating on growth outlook

Stifel initiated coverage of Celsius Holdings (CELH) with a buy rating and a $47 price target, citing expectations for improved sales growth driven by innovation, marketing, and the recent Alani Nu acquisition, which is expected to provide synergies in 2026. The firm projects sales to accelerate in the second half of 2025, supported by modest distribution expansion and easier year-over-year comparisons, while other analysts from Truist, Piper Sandler, and Jefferies have also raised their price targets, reflecting optimism about the company's growth trajectory. Despite a TD Cowen's neutral outlook, Celsius's strong financial health, including a 10.5% share of the U.S. energy drink market and a 50.4% gross profit margin, positions it well for expansion.

Analysis

Stifel has initiated coverage on Celsius Holdings (CELH) with a buy rating and a $47.00 price target, citing expectations for improving sales growth for the energy drink maker, which currently holds a market valuation of $10.8 billion. This outlook is supported by Celsius's "GREAT" InvestingPro Overall Score of 3.22, indicating strong financial health, robust cash flow metrics, a healthy current ratio of 3.38, and a balance sheet with more cash than debt. Stifel anticipates the Celsius brand will benefit from improving sales velocities and distribution growth, driven by innovation and marketing initiatives, as well as the recent acquisition of Alani Nu. This $1 billion acquisition is expected to provide greater scale, a portfolio of leading functional brands, and profit growth through deal synergies anticipated in 2026. Post-acquisition, Celsius Holdings now represents over 16% of the U.S. energy drink category, an increase from the Celsius brand's consistent 10.5% share maintained over the past 30 weeks. The company's strong fundamentals include a 50.4% gross profit margin and positive earnings expectations for the current year. Stifel projects Celsius brand sales will accelerate in the second half of 2025, aided by modest distribution expansion and more favorable year-over-year comparisons, with slightly positive year-over-year sales growth expected in Q2 2025. Other analysts share this optimism, with Truist Securities, Piper Sandler, and Jefferies raising their price targets to $50, $45, and $45 respectively, highlighting the Alani Nu acquisition's potential synergies (projected at $50 million by Jefferies) and strong retail sales growth. In contrast, TD Cowen maintains a Hold rating with a $37 target. Celsius has also increased its authorized common stock from 300 million to 400 million shares and approved new stock plans to incentivize and retain talent.

Key Decisions for Investors

• Investors should consider the largely positive analyst sentiment, highlighted by Stifel's buy rating and price target increases from multiple firms, alongside Celsius's strong financial health, significant market share post-Alani Nu acquisition (over 16%), and robust 50.4% gross profit margin when evaluating an investment.
• Monitor Celsius's U.S. sales, market share trends, and the successful integration of Alani Nu, as these are crucial for achieving the projected sales acceleration in H2 2025 and realizing anticipated synergies, which are key catalysts for the stock.
• Factor in the potential for share dilution resulting from the increase in authorized common stock to 400 million shares and the implementation of new stock incentive plans, which could impact future earnings per share.